[1] He Q, He W, Dong H, et al. Role of liver sinusoidal endothelial cell in metabolic dysfunction-associated fatty liver disease [J]. Cell Commun Signal, 2024, 22(1): 346-64.
[2] Cabral F, Al-Rahem M, Skaggs J, et al. Stabilin receptors clear LPS and control systemic inflammation [J]. iScience, 2021, 24(11): 103337.
[3] He F, Ru X, Wen T. NRF2, a transcription factor for stress response and beyond [J]. Int J Mol Sci, 2020, 21(13):4777-4800.
[4] Jiang X, Stockwell B R, Conrad M. Ferroptosis: mechanisms, biology and role in disease [J]. Nat Rev Mol Cell Biol, 2021, 22(4): 266-282.
[5] Dixon S J, Lemberg K M, Lamprecht M R, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death [J]. Cell, 2012, 149(5): 1060-1072.
[6] Zhang Y, Li M, Guo Y, et al. The organelle-specific regulations and epigenetic regulators in ferroptosis [J]. Front Pharmacol, 2022, 13: 905501.
[7] Addo L, Tanaka H, Yamamoto M, et al. Hepatic nerve growth factor induced by iron overload triggers defenestration in liver sinusoidal endothelial cells [J]. Biochim Biophys Acta, 2015, 1852(1): 175-183.
[8] Biquard L, Rautou P E. Autophagy and extracellular vesicles in the liver endothelium: friends or foes? [J]. Hepatol Int, 2024, 18(1): 1-3.
[9] Ramani K, Mavila N, Abeynayake A, et al. Correction: targeting A-kinase anchoring protein 12 phosphorylation in hepatic stellate cells regulates liver injury and fibrosis in mouse models [J]. Elife, 2023, 12:e88586.
[10] Chen H, Zhao W, Yan X, et al. Overexpression of hepcidin alleviates steatohepatitis and fibrosis in a diet-induced nonalcoholic steatohepatitis [J]. J Clin Transl Hepatol, 2022, 10(4): 577-588.
[11] Gao H, Jin Z, Bandyopadhyay G, et al. Aberrant iron distribution via hepatocyte-stellate cell axis drives liver lipogenesis and fibrosis [J]. Cell Metab, 2022, 34(8): 1201-1213.e5.
[12] Yang Y, Wang Y, Guo L, et al. Interaction between macrophages and ferroptosis [J]. Cell Death Dis, 2022, 13(4): 355-365.
[13] Jiang Q, Wan R, Jiang J, et al. Interaction between macrophages and ferroptosis: metabolism, function, and diseases [J]. Chin Med J (Engl), 2024, 138(5): 509-522.
[14] Zeng J, Qin L, Jin Q, et al. Prevalence and characteristics of MAFLD in Chinese adults aged 40 years or older: a community-based study [J]. Hepatobiliary Pancreat Dis Int, 2022, 21(2): 154-161.
[15] Rinella M E, Neuschwander-Tetri B A, Siddiqui M S, et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease [J]. Hepatology, 2023, 77(5): 1797-1835.
[16] Imarisio C, Alchera E, Bangalore Revanna C, et al. Oxidative and ER stress-dependent ASK1 activation in steatotic hepatocytes and Kupffer cells sensitizes mice fatty liver to ischemia/reperfusion injury [J]. Free Radic Biol Med, 2017, 112: 141-148.
[17] Liu S, Zhang L, Xu J, et al. Identification of Ferroptosis -Related Genes in MAFLD/MASH and HQHF Validation [J]. Hepat Med, 2025, 17: 13-24.
[18] Jian Y, Li Y, Zhou Y, et al. Pollutants in microenvironmental cellular interactions during liver inflammation cancer transition and the application of multi-omics analysis [J]. Toxics, 2025, 13(3):163-179.
[19] Wan L Y, Peng H, Ni Y R, et al. The miR-23b/27b/24-1 cluster inhibits hepatic fibrosis by inactivating hepatic stellate cells [J]. Cell Mol Gastroenterol Hepatol, 2022, 13(5): 1393-1412.
[20] Duan L, Yao Y, Kong H, et al. Chemokines and chemokine receptors: potential therapeutic targets in systemic lupus erythematosus [J]. Cytokine, 2024, 184: 156770.
[21] Du Z, Lin Z, Wang Z, et al. SPOCK1 overexpression induced by platelet-derived growth factor-BB promotes hepatic stellate cell activation and liver fibrosis through the integrin α5β1/PI3K/Akt signaling pathway [J]. Lab Invest, 2020, 100(8): 1042-1056.
[22] Glässner A, Eisenhardt M, Krämer B, et al. NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner [J]. Lab Invest, 2012, 92(7): 967-977.
[23] Hassannia B, Vandenabeele P, Vanden Berghe T. Targeting ferroptosis to iron out cancer [J]. Cancer Cell, 2019, 35(6): 830-849.
[24] Vechalapu S K, Kumar R, Sachan S K, et al. Copper and manganese complexes of pyridinecarboxaldimine induce oxidative cell death in cancer cells [J]. ACS Appl Bio Mater, 2024, 7(10): 6696-6705.
[25] Suthiram K T, Ghazi T, Abdul N S, et al. Kojic acid induces oxidative stress and anti-inflammatory effects in human hepatocellular carcinoma (HepG2) cells [J]. Toxicon, 2023, 232: 107221.
[26] Mohammadian K, Fakhar F, Keramat S, et al. The role of antioxidants in the treatment of metabolic dysfunction-associated fatty liver disease: a systematic review [J]. Antioxidants (Basel), 2024, 13(7):797-836.
[27] Yu C, Xu Y, Zhao M, et al. New insights into mechanism of ellagic acid alleviating arsenic-induced oxidative stress through MAPK/keap1-Nrf2 signaling pathway response, molecular docking and metabolomics analysis in HepG2 cells [J]. Ecotoxicol Environ Saf, 2024, 285: 117029.
[28] Khadrawy S M, Mohamed H M, Mahmoud A M. Mesenchymal stem cells ameliorate oxidative stress, inflammation, and hepatic fibrosis via Nrf2/HO-1 signaling pathway in rats [J]. Environ Sci Pollut Res Int, 2021, 28(2): 2019-2030.
[29] Li N, Wang R, Ai X, et al. Electroacupuncture inhibits neural ferroptosis in rat model of traumatic brain injury via activating system Xc(-)/GSH/GPX4 Axis [J]. Curr Neurovasc Res, 2024, 21(1): 86-100.
[30] Meng F, Xiao Y, Ji Y, et al. An open-like conformation of the sigma-1 receptor reveals its ligand entry pathway [J]. Nat Commun, 2022, 13(1): 1267-1278.
[31] Wu Z, Khodade V S, Chauvin J R, et al. Hydropersulfides inhibit lipid peroxidation and protect cells from ferroptosis [J]. J Am Chem Soc, 2022, 144(34): 15825-15837.
[32] Lu C, Xu C, Li S, et al. Liraglutide and GLP-1(9-37) alleviated hepatic ischemia-reperfusion injury by inhibiting ferroptosis via GSK3β/Nrf2 pathway and SMAD159/Hepcidin/FTH pathway [J]. Redox Biol, 2025, 79: 103468.
[33] Sun D, Wang L, Wu Y, et al. Lipid metabolism in ferroptosis: mechanistic insights and therapeutic potential [J]. Front Immunol, 2025, 16: 1545339. |
